25 Leading Drug Discovery Services Companies Shaping Innovation and Market Growth
Discover the top 25 companies transforming the drug discovery services market, including Thermo Fisher Scientific Inc., Charles River Laboratories, WuXi AppTec, and other industry leaders. Backed by a market projected to grow from $16.36 billion to $27.23 billion by 2030 at a CAGR of 10.7%, this analysis highlights competitive strengths, breakthrough innovations, and strategic moves shaping the future...
30 Leading Biosimilars Companies Shaping Innovation and Market Growth
Discover the top 30 companies transforming the biosimilars market, including Sandoz Group AG, Pfizer Inc., Amgen Inc., and other industry leaders. Backed by a market projected to grow from $35.04 billion to $72.29 billion by 2035 at a CAGR of 7.5%, this analysis highlights competitive strengths, breakthrough innovations, and strategic moves shaping the future of the industry. Access the full market...
36 Leading Pharmaceutical Contract Manufacturing Companies Shaping Innovation and Market Growth
Discover the top 36 companies transforming the pharmaceutical contract manufacturing market, including Thermo Fisher Scientific Inc., Lonza, Catalent, Inc., and other industry leaders. Backed by a market projected to grow from $209.90 billion to $311.95 billion by 2030 at a CAGR of 8.2%, this analysis highlights competitive strengths, breakthrough innovations, and strategic moves shaping the future...
27 Leading Contract Research Organization Services Companies Shaping Innovation and Market Growth
Discover the top 27 companies transforming the contract research organization (CRO) services market, including IQVIA Inc., ICON plc, Thermo Fisher Scientific Inc., and other industry leaders. Backed by a market projected to grow from $84.61 billion to $125.95 billion by 2030 at a CAGR of 8.3%, this analysis highlights competitive strengths, breakthrough innovations, and strategic moves shaping the...
41 Leading In Vitro Diagnostics Companies Shaping Innovation and Market Growth
Discover the top 41 companies transforming the in vitro diagnostics market, including Danaher, F. Hoffmann-La Roche Ltd, Abbott, and other industry leaders. Backed by a market projected to grow from $109.06 billion to $157.63 billion by 2030 at a CAGR of 7.6%, this analysis highlights competitive strengths, breakthrough innovations, and strategic moves shaping the future of the industry. Access the...
Drug Screening Market worth $21.29 billion by 2030
The global drug screening market, valued at US$8.92 billion in 2024, stood at US$10.36 billion in 2025 and is projected to advance at a resilient CAGR of 15.5% from 2025 to 2030, culminating in a forecasted valuation of US$21.29 billion by the end of the period.
The market for drug screening is being fueled by growing workplace and clinical testing programs, an increased need for opioid/polysubstance...
Genomic Biomarkers Market to Reach $50.31 Billion by 2030
According to recent market analysis, the Genomic Biomarkers Market is projected to grow from USD 29.00 billion in 2025 to USD 50.31 billion by 2030, registering a robust CAGR of 11.6% during the forecast period. This growth reflects the increasing reliance on genomic insights to enhance clinical decision-making and therapeutic outcomes. The global genomic biomarkers market is witnessing...
ECG Sensor Patches Market: Bridging Wearables, Data Analytics, and Cardiac Insights
The global ECG Sensor Patches Market, valued at US$0.95 billion in 2024 stood at US$1.05 billion in 2025 and is projected to advance at a resilient CAGR of 12.0% from 2025 to 2032, culminating in a forecasted valuation of US$2.32 billion by the end of the period. The growth is mainly attributed to the rising target patient population and increasing cases of...
Pharmaceutical Drying Equipment Market Size and Growth Forecast North America (US, Canada), Europe (Germany, France, UK, Italy, Spain, Netherlands), Asia Pacific (Japan, China, India, Australia), Latin America (Brazil, Mexico, Argentina)
The global pharmaceutical drying equipment market was valued at US$5.45 billion in 2023 and US$5.80 billion in 2024. It is projected to grow at a CAGR of 7.1% from 2024 to 2029, reaching a forecasted valuation of US$8.18 billion by the end of the period. This growth is primarily fueled by the expansion of manufacturing facilities, rising demand for biopharmaceuticals, and the rapid development of...
Molecular Quality Controls Market Size and Growth Forecast North America (US, Canada), Europe (Germany, France, UK, Italy, Spain, Netherlands), Asia Pacific (Japan, China, India, Australia), Latin America (Brazil, Mexico, Argentina)
The global molecular quality controls market was valued at US$ 0.2 billion in 2023 and is projected to reach US$ 0.3 billion by 2028. This growth represents a resilient compound annual growth rate (CAGR) of 6.6% during the forecast period from 2023 to 2028. The market expansion is primarily driven by the increasing number of accredited clinical laboratories, the growing adoption of third-party quality...